StevenESchildMD(He/Him)

PubMed

• 2472 citations
  Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
  Julian R. Molina, Ping Yang, Stephen D. Cassivi, Steven E. Schild, Alex A. Adjei
  Mayo Clinic Proceedings. 2008-05-01
• 33 citations
  Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer.
  Lukas Käsmann, Louisa Bolm, Steven E. Schild, Stefan Janssen, Dirk Rades
  Lung. 2017-02-02
• 136 citations
  Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression.
  Dirk Rades, Marisa Lange, Theo Veninga, Lukas J.A. Stalpers, Amira Bajrovic
  International Journal of Radiation Oncology, Biology, Physics. 2011-02-01

Journal Articles

• A Novel and Individualized Robust Optimization Method Using Normalized Dose Interval Volume Constraints (NDIVC) for Intensity‐Modulated Proton Radiotherapy  
  Terence T Sio, Steven E Schild, Wei Liu, Medical Physics
• Nuclear expression of p65 (rela) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck  
  Rades D, Huttenlocher S, Seibold ND, Gebhard MP, Thorns C, Hasselbacher K, Wollenberg B, Schild SE, BMC Cancer, 1/6/2015
• A new tool predicting survival after radiosurgery alone for one or two cerebral metastases from lung cancer  
  Rades D, Huttenlocher S, Dziggel L, Khoa MT, Van Thai P, Hornung D, Schild SE, Lung, 1/1/2015
• A New tool to predict survival after radiosurgery alone for newly diagnosed cerebral metastases  
  Rades D, Huttenlocher S, Dziggel L, Blanck O, Hornung D, Mai KT, Ngo TT, Van Pham T, Schild S, Asian Pacific Journal of Cancer Prevention, 1/1/2015
• Non-small cell lung cancer, version 62015 featured updates to the nccn guidelines  
  Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Dilling TJ, Dobelbower MC, Govindan R, Grannis FW,..., J. Natl. Compr. Cancer Netw, 1/1/2015
• Radiation therapy for oligometastatic non-small cell lung cancer  
  Salama JK, Schild SE, Cancer Metastasis Rev, 1/1/2015
• SU-E-J-229: Magnetic Resonance Imaging of Small Fiducial Markers for Proton Beam Therapy  
  Hu Y, James J, Panda A, Vargas C, Silva A, Liu W, Shen J, Ding X, Paden R, Hanson J, Wong W, Schild S, Bues M, Med Phys, 1/1/2015
• SU-E-T-349: Effective Dose-Volume-Histogram Prediction Method Using Euclidean Distance Volume Histogram for Volumetric Modulated Arc Therapy to Treat Prostate Cancer  
  Shin J, Liang J, Schild S, Wong W, Liu W, Med Phys, 1/1/2015
• SU-E-T-618: Plan Robustness Study of Volumetric-Modulated Arc Therapy Vs Intensity-Modulated Radiation Therapy for Head and Neck Cancer  
  Liu W, Patel S, Shen J, Harrington D, Stoker J, Ding X, Hu Y, Wong W, Halyard M, Schild S, Ezzell G, Bues M, Med Phys, 1/1/2015
• SU-E-T-803: Verification of QUANTEC Lyman Kutcher Burman (LKB) Model for Grade>=2(2+) Late Rectal Complication Rates Using a Database of 79 Prostate Patients Treate...  
  Fatyga M, Schild S, Vora S, Schild M, Wong W, Liu X, Li J, Wu T, Med Phys, 1/1/2015
• SU-F-BRD-01: A Novel 4D Robust Optimization Mitigates Interplay Effect in Intensity-Modulated Proton Therapy for Lung Cancer  
  Liu W, Schild S, Chang J, Liao Z, Wen Z, Shen J, Stoker J, Wong W, Sahoo N, Herman M, Mohan R, Bues M, Med Phys, 1/1/2015
• TH-AB-304-02: Fitting Grade>=2(2+) Acute Rectal Complication Rates in Prostate Cancer Patients to Lyman Kutcher Burman (LKB) and Logistic Regression NTCP Models Usi...  
  Liu X, Fatyga M, Li J, Schild M, Schild S, Vora S, Wong W, Wu T, Med Phys, 1/1/2015
• A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression  
  Rades D, Evers JN, Rudat V, Bajrovic A, Karstens JH, Schild SE, BMC Cancer, 1/14/2014
• Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer  
  Rades D, Huttenlocher S, Hornung D, Blanck O, Schild SE, BMC Cancer, 1/11/2014
• Re-irradiation of spinal cord compression due to metastasis in elderly patients  
  Rades D, Evers JN, Bajrovic A, Veninga T, Schild SE, Anticancer Res, 1/1/2014
• Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck  
  Huttenlocher S, Seibold ND, Gebhard MP, Noack F, Thorns C, Hasselbacher K, Wollenberg B, Schild SE, Rades DMD, Strahlenther Onkol, 1/1/2014
• Estimating survival of patients receiving radiosurgery alone for cerebral metastasis from melanoma  
  Sehmisch L, Huttenlocher S, Schild SE, Rades D, J Dermatol, 1/1/2014
• A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone  
  Huttenlocher S, Dziggel L, Hornung D, Blanck O, Schild SE, Rades D, Radiat. Oncol., 1/1/2014
• A new prognostic factor for the survival of patients with renal cell carcinoma developing metastatic spinal cord compression  
  Rades D, Weber A, Bartscht T, Bajrovic A, Karstens JH, Schild SE, Strahlenther Onkol, 1/1/2014
• Number of extraspinal organs with metastases: a prognostic factor of survival in patients with metastatic spinal cord compression (mscc) from non-small cell lung cance...  
  Rades D, Weber A, Karstens JH, Schild SE, Bartscht T, Anticancer Res, 1/1/2014
• A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients  
  Evers JN, Schild SE, Segedin B, Nagy V, Khoa MT, Trang NT, Rades D, Anticancer Res, 1/1/2014
• Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck  
  Rades D, Seibold ND, Gebhard MP, Noack F, Bruchhage KL, Schild SE, Strahlenther Onkol, 1/1/2014
• A survival score for patients with brain metastases from less radiosensitive tumors treated with whole-brain radiotherapy alone  
  Dziggel L, Segedin B, Podvrsnik NH, Oblak I, Schild SE, Rades D, Strahlenther Onkol, 1/1/2014
• Predicting the presence of extracranial metastases in patients with brain metastases upon first diagnosis of cancer  
  Rades D, Segedin B, Nagy V, Schild SE, Trang NT, Khoa MT, Strahlenther Onkol, 1/1/2014
• Breast cancer patients with metastatic spinal cord compression  
  Weber A, Bartscht T, Karstens JH, Schild SE, Rades D, Strahlenther Onkol, 1/1/2014
• Join now to see all

Books/Book Chapters

• Radiation Oncology: Difficult Cases and Practical Management 
  Chapter: Major opinion. 
  Page 179 - 181Schild SEEditors: Small W Jr; Williams TR; Donnelly ED.Demos Medical, NY2013
• Principles and Practice of Stereotactic Radiosurgery 
  Chapter: Pineal tumors: fractionated radiation therapy perspective. 
  Page 371 - 376Schild SEEditors: Chin LS, Regine WF.Springer, NY2008
• Clinical Radiation Oncology 
  Chapter: Small cell lung cancer. 
  Page 897 - 909Schild SE, Curran WJ JrEditors: Gunderson LL, Tepper JE.Elsevier Churchill Livingstone, PhiladelphiaEdition 2nd,2007
• Mayo Clinic Gastrointestinal Surgery 
  Chapter: Cancer of the rectum. 
  Page 569 - 588Heppell JP, McConnell EJ, Schild SEEditors: Kelly KA, Sarr MG, Hinder RA.W. B. Saunders Co., Philadelphia2004
• Colorectal Cancer : A Clinical Guide To Therapy 
  Chapter: Treatment of locally advanced primary and locally recurrent colorectal cancer. 
  Page 205 - 228Gunderson LL, Nelson H, Haddock MG, Devine R, Wolff B, Dozois R, Schild S, Pemberton J, Young-Fadok TEditors: Bleiberg H, et al.Martin Dunitz, London2002
• Clinical Oncology: A Multidisciplinary Approach for Physicians and Students 
  Chapter: Central nervous system tumors. 
  Page 789 - 822Nelson DF, Jenkins RB, Scheithauer BW, Raffel C, Dinapoli R, Schild SE, Brasacchio RA, Korones DNEditors: Rubin P.W. B. Saunders Co., PhiladelphiaEdition 8th,2001
• Clinical Radiation Oncology 
  Chapter: Colon cancer. 
  Page 719 - 727Willett CG, Schild SEEditors: Gunderson LL, Tepper JE.Churchill Livingstone2000
• Treatment Planning in Radiation Oncology 
  Chapter: Cancers of the gastrointestinal tract. 
  Page 319 - 342Martenson JA, Schild SE, Haddock MGEditors: Khan FM, Potish RA.Williams & Wilkins, Baltimore1998
• Cancer of the Colon, Rectum, and Anus 
  Chapter: External radiation therapy for primary locally advanced rectal cancer. 
  Page 695 - 701Martenson JA Jr, Schild SEEditors: Cohen AM, et al.McGraw-Hill, Inc., NY1995
• Join now to see all

Abstracts/Posters

• Magnetic resonance imaging of small fiducial markers for proton beam therapy.
  Hu Y, James J, Panda A, Vargas C, Silva A, Liu W, Shen J, Ding X, Paden R, Hanson J, Wong W, Schild S, Bues M, Med Phys, 1/1/2015
• Effective dose-volume-histogram prediction method using euclidean distance volume histogram for volumetric modulated arc therapy to treat prostate cancer.
  Shin J, Liang J, Schild S, Wong W, Liu W, Med Phys, 1/1/2015
• Plan robustness study of volumetric-modulated arc therapy vs. intensity-modulated radiation therapy for head and neck cancer.
  Liu W, Patel S, Shen J, Harrington D, Stoker J, Ding X, Hu Y, Wong W, Halyard M, Schild S, Ezzell G, Bues M, Med Phys, 1/1/2015
• Ptv is the voxel-wise worst-case of ctv in prostate photon therapy.
  Harrington D, Schild S, Wong W, Vora S, Liu W, Med Phys, 1/1/2015
• Verification of quantec lyman kutcher burman (lkb) model for grade>=2(2+) late rectal complication rates using a database of 79 prostate patients treated with imrt.
  Fatyga M, Schild S, Vora S, Schild M, Wong W, Liu X, Li J, Wu T, Med Phys, 1/1/2015
• A novel 4d robust optimization mitigates interplay effect in intensity-modulated proton therapy for lung cancer.
  Liu W, Schild S, Chang J, Liao Z, Wen Z, Shen J, Stoker J, Wong W, Sahoo N, Herman M, Mohan R, Bues M, Med Phys, 1/1/2015
• Fitting grade >=2(2+) acute rectal complication rates in prostate cancer patients to Lyman Kutcher Burman (lkb) and logistic regression ntcp models using dosimetry ...
  Liu X, Fatyga M, Li J, Schild M, Schild S, Vora S, Wong W, Wu T, Med Phys, 1/1/2015
• Charged particle therapy for nasal cavity and paranasal sinus malignancies: a systematic review and meta-analysis.
  Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Khaled MS, Alandab F, Altayar O, Nabhan M, Schild SE, Foote RL, Int J Radiat Oncol Biol Phys, 1/1/2014
• Understanding the characteristics and types of adult and pediatric cancers treated with proton beam radiation therapy in a population of 88 million commercially insure...
  Miller RC, Van Houten H, Foote RL, Keole S, Schild SE, Laack NN, Childs SK, Daniels TB, Crown WH, Shah ND, Int J Radiat Oncol Biol Phys, 1/1/2014
• Stereotactic Body Radiotheraphy for Oligometastatic Disease to the Lung.
  Steven E. Schild, MD, 15th World Congress on Lung Cancer, Sydney, Australia, 1/1/2013
• A randomized double-blind phase II study of the Seneca Valley virus (NTX-010) versus placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or respon...
  Molina JR, Mandrekar SJ, Dy K, Aubry MC, Allen Ziegler, Dakhil SR, Sachs BA, Nieva JJ, Schild SE, Burroughs K, Williams A, Rudin CM, Adjei AA, J Clin Oncol, 1/1/2013
• Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung canc...
  Foster NR, Renfro LA, Schild SE, Redman MW, Wang XF, Dahlberg SE, Ding K, Bradbury PA, Ramalingam SS, Gandara DR, Vokes EE, Adjei AA, Mandrekar SJ, J Clin Oncol, 1/1/2013
• A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell ...
  Bradley JD, Paulus R, Komaki R, Masters GA, Forster K, Schild SE, Bogart J, Garces YI, Narayan S, Kavadi V, Nedzi LA, Michalski JM, Johnson D, MacRae RM, Curran WJ, Ch..., J Clin Oncol, 1/1/2013
• Scoring system predicting overall survival (OS) in patients (Pts) with non-small cell lung cancer (NSCLC).
  Schild SE, Tan AD, Wampfler JA, Molina JR, Ross HJ, Yang P, Sloan JA, J Clin Oncol, 1/1/2013
• Radiation therapy oncology group (rtog) protocol 0915: a randomized phase 2 study comparing 2 stereotactic body radiation therapy (sbrt) schedules for medically inoper...
  Videtic GM, Hu C, Singh A, Chang JY, Parker W, Olivier K, Schild S, Komaki R, Urbanic J, Choy H, Int J Radiat Oncol Biol Phys, 1/1/2013
• Stereotactic body radiotherapy for oligometastatic disease to the lung.
  Ashman J, Goyal U, Vora S, Clouser E, Jaroszewski D, Dueck A, Paripati H, Wesselius L, Rule W, Ross HJ, Schild S, J Thorac Oncol, 1/1/2013
• Radiation therapy oncology group (rtog) protocol 0915: a randomized phase ii study comparing 2 stereotactic body radiation therapy (sbrt) schedules for medically inope...
  Videtic G, Hu C, Singh A, Chang J, Parker W, Olivier K, Schild S, Komaki R, Urbanic J, Choy H, J Thorac Oncol, 1/1/2013
• An intergroup randomized phase III comparison of standard-dose (60 gy) versus high-dose (74 gy) chemoradiotherapy (crt) +/-cetuximab (cetux) for stage III non-small ce...
  Bradley J, Masters G, Hu C, Blumenschein G, Bogart J, Schild S, Michalski JM, Kavadi V, Garces YI, Narayan S, Nedzi L, Robinson CG, Wynn RB, Paulus R, Curran WJ, Choy H, J Thorac Oncol, 1/1/2013
• Impact of disease progression (DP) date determination method on post progression survival (PPS) and DP metrics in advanced lung cancer.
  Mandrekar SJ, Foster NR, Qi Y, Dy GK, Jatoi A, Molina JR, Jett JR, Stella PJ, Schild SE, Adjei AA, J Clin Oncol, 1/1/2012
• N0321: A phase II study of bortezomib, paclitaxel, carboplatin, and radiotherapy for locally advanced non-small cell lung cancer.
  Schild SE, Molina JR, Dy GK, Rowland KM, Sarkaria JN, Thomas SP, Northfelt DW, Kugler JW, Foster NR, Adjei AA, J Clin Oncol, 1/1/2012
• Subsequent survival not impacted by disease progression date determination method in advanced lung cancer.
  Qi Y, Foster NR, Dy GK, Jatoi A, Molina JR, Jett JR, Rowland KM, Stella PJ, Schild SE, Adjei AA, Mandrekar SJ, J Clin Oncol, 1/1/2012
• Long-term survival of patients(pts) treated with high-dose radiotherapy(rt) & concurrent chemotherapy for unresectable non-small cell lung cancer(nsclc).
  Schild SE, Hillman S, Graham D, Vora S, Garces Y, Olivier K, Kugler J, Ross H, Molina J, Adjei A, J Thorac Oncol, 1/1/2012
• Stereotactic body radiation therapy (sbrt) for oligometastases to the lung: initial outcome and toxicity analysis.
  Goyal U, Vora SA, Ashman JB, Clouser E, Jaroszewski DE, Dueck AC, Ross HJ, Paripati H, Wesselius L, Schild SE, J Thorac Oncol, 1/1/2012
• Nine-year outcome and toxicity in patients treated with imrt for clinically localized prostate cancer.
  Vora S, Wong WW, Schild S, Ezzell G, Int J Radiat Oncol Biol Phys, 1/1/2012
• Five-year outcome of a prospective study evaluating hypofractionated whole breast external beam irradiation and tumor bed boost with intra-operative electron irradiati...
  Wong WW, Pockaj BA, Vora SA, Halyard MY, Gray RJ, Schild SE, Int J Radiat Oncol Biol Phys, 1/1/2011
• Join now to see all

Lectures

• A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell ... 
  Chicago, IL - 1/1/2013
• Scoring system predicting overall survival (OS) in patients (Pts) with non-small cell lung cancer (NSCLC). 
  Chicago, IL - 1/1/2013
• A randomized double-blind phase II study of the Seneca Valley virus (NTX-010) versus placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or respon... 
  Chicago, IL - 1/1/2013
• Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung canc... 
  Chicago, IL - 1/1/2013
• An intergroup randomized phase III comparison of standard-dose (60 Gy) vs high-dose (74 Gy) chemoradiotherapy (CRT) +/-cetuximab (cetux) for stage III non-small cell l... 
  Sydney, Australia - 1/1/2013
• Radiation Therapy Oncology Group (RTOG) protocol 0915: A randomized phase II study comparing 2 Stereotactic Body Radiation Therapy (SBRT) schedules for medically inope... 
  Sydney, Australia - 1/1/2013
• "Lung Cancer" 
  Phoenix, AZ - 1/1/2012
• "Radiotherapy for Lung Cancer" 
  Phoenix, AZ - 1/1/2012
• Accelerated or Hyperfractionated Radiotherapy (RT) in Non-metastatic Lung Cancer (LC): Individual Patient Data (IPD) Meta-analysis from 2279 Patients (PTS). 
  Geneva, Switzerland - 1/1/2010
• A Prospective Study Evaluating Tumor Bed Boost with Intra-operative Electron Irradiation (IOERT) in Breast Conserving Treatment for T1/2 N0 Breast Cancer. 
  Cancun, Mexico - 1/1/2010
• A Phase III Comparison of Prophylactic Cranial Irradiation (PCI) versus Observation in Patients with Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC). Initial An... 
  San Francisco, CA - 1/1/2009
• A Phase II Study of the VEGFR Inhibitor Pazopanib (P) in Patients with Newly Diagnosed or Relapsed Malignant Pleural Mesothelioma (MPM): an NCCTG Study. 
  San Francisco, CA - 1/1/2009
• Phase II trial (N0621) of the c-Src inhibitor AZD-0530 after 4 cycles of chemotherapy for patients with Extensive Stage Small Cell Lung Cancer (ED-SCLC). 
  San Francisco, CA - 1/1/2009
• Survival of patients treated with high-dose radiotherapy & concurrent chemotherapy for unresectable non-small cell lung cancer. 
  San Francisco, CA - 1/1/2009
• Radiation Dose Escalation for Localized Prostate Cancer: Intensity Modulated Radiation Therapy Compared with Permanent Transperineal Brachytherapy. 
  Orlando, FL - 1/1/2009
• Comparison of the Outcomes of Various Radiation Treatment Modalities for Prostate Cancer. 
  Los Angeles, CA - 1/1/2007
• Salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer: Dose response analysis. 
  1/1/2007
• The use of fused ProstaScint CT scans in planning IMRT for prostate cancer. 
  1/1/2007
• "Current Management of Locally Advanced Non-small Cell Lung Cancer" 
  Amelia Island, FL - 1/1/2006
• Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. 
  1/1/2006
• Comparison of Two Radiochemotherapy (RCT) Schedules for Locally Advanced Squamous Cell Head and Neck Cancer. 
  Berlin, Germany - 1/1/2006
• Treatment of Stage III Non-Small Cell Lung Cancer in the Elderly. 
  Atlanta, GA - 1/1/2006
• Current Management of Locally Advanced Non-Small Cell Lung Cancer. 
  Amelia Island, FL - 1/1/2006
• The Therapy of Locally Advanced Non-Small Cell Lung Cancer in the Elderly. 
  The Hague, Netherlands - 1/1/2006
• "Innovations in the Radiotherapy of Non-small Cell Lung Cancer" 
  Scottsdale, AZ - 1/1/2005
• Join now to see all

Other

• A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-Brain Irradiation in Patients with Head-and-Neck Cancer 
  Steven Schild, MD, Anticancer Research
  https://www.doximity.com/articles/375b8850-5449-4c06-9476-7f4d79afc02b
  UpToDate, Wolters Kluwer Health - 2012-03-28
• Hyperfractionated or Accelerated Hyperfractionated Re-Irradiation with ≥42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer 
  Steven Schild, MD, Anticancer Research
  https://www.doximity.com/articles/108dbb19-d80e-4793-bd48-cbe41516d879
  UpToDate, Wolters Kluwer Health - 2012-09-04
• Validation of a Survival Score for Patients Receiving Radiosurgery or Fractionated Stereotactic Radiotherapy for 1 to 3 Brain Metastases 
  Steven Schild, MD, Anticancer Research
  https://www.doximity.com/articles/de5b3c76-e7e2-48f7-a00c-2aa84b758eaf
  UpToDate, Wolters Kluwer Health - 2012-10-04
• Challenges of anemia correction during radiotherapy and chemoradiation. 
  Rades D, Schild SE, Memo-Magazine of European Medical Oncology
  1/1/2012
• Management of stage I and stage II non-small cell lung cancer. 
  Steven E. Schild, MD, UptoDate (Rose BD, Ed)
  Wellesley, MA - 1/1/2002
• Management of Stage III Non-Small Cell Lung Cancer. 
  Strauss, GM, Schild SE, UptoDate (Rose BD, Ed)
  Wellesley, MA - 1/1/2002
• Pancoast's Syndrome and Superior (Pulmonary) Sulcus Tumors. 
  Arcasoy SM, Jett JR, Schild SE, UptoDate (Rose BD, Ed)
  Wellesley, MA - 1/1/2002
• The Evaluation and Treatment of Biochemical Failure following Radical Prostatectomy. 
  Ferrigni RG, Schild SE, AUA Update Series
  1/1/1999
• The results of radiotherapy for chemodectomas 
  Schild SE, Foote RL, Bock E, Buskirk SJ, Cupps RE, Earle JD
  1/1/1990
• Join now to see all